ANTHONY J MADDALUNA
CIK 1566333 · Executive Vice President · last filed 2025-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.68M
Companies
4
Total Filings
120
Lifetime Open-Market Net
-$6.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDP | Director | — | $1.29 | — | $0 | 6 | 2025-06-11 |
| Intec Pharma Ltd. (NTEC) Delisted | Director | 53,570 | $9.63 | $515.9K | $11.8K | 3 | 2020-07-17 |
| ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Director | 11,210 | — | — | $25.0K | 4 | 2017-02-10 |
| PFE | Executive Vice President | 166,789 | $28.07 | $4.68M | -$6.37M | 106 | 2017-01-03 |
Recent Filings · Page 3 of 12
120 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-07 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-10-04 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-09-19 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-09-01 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-08-16 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-08-01 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-07-19 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-07-08 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-07-05 | PFE | Grant (A) | — | $0 | EDGAR |
| 2016-06-16 | ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Grant (A) | +3,036 | $45.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.